Indian API Market Outlook 2022 - Patent Expiry of Blockbuster Drugs Drives the Market - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Indian API Market Outlook 2022" report to their offering.

According to report on Indian API Market Outlook 2022, the Indian API domestic consumption market is forecasted to grow at a CAGR of around 10% from FY 2016-FY 2022. This report provides the share of India in the global API market. Furthermore, it gives information about the current scenario of the Indian API market, and future forecasts related to it. RNCOS analysts have mentioned the major drivers of the market, and factors hindering growth of the market.

The Indian API market has been segmented on the basis of various parameters, such as type of manufacturing, type of API, and type of therapeutic area. Moreover, the report highlights the mergers and acquisitions that have taken place in the Indian API market. The regulatory scenario governing the Indian API market along with the various government initiatives for the development of this industry have also been mentioned in the report. Furthermore, the report provides the details about major mergers and acquisitions occurred in the industry.

The last section of the report discusses about the key players in Indian API industry. A brief business overview and financial information about each of these players has been provided in the report. The recent development and strength-weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of major players. In the end, the areas of opportunities and recommendations for the growth of this industry have also been highlighted in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Indian API market.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. India API Industry Outlook

4. Drivers & Challenges

5. Market Segmentation

6. Mergers and Acquisitions

7. Government Initiatives

8. Regulatory Scenario

9. Competitive Landscape

10. Opportunities and Recommendations

Companies Mentioned

- Aurobindo Pharma Limited

- Biocon

- Cipla Limited

- Dr. Reddy's Laboratories

- Glenmark Pharmaceuticals

- Jubilant LifeSciences

- Lupin Limited

- Sun Pharma

- Wockhardt

- Zydus Cadila

For more information visit http://www.researchandmarkets.com/research/wmd42x/indian_api_market

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Software Design and Development

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Software Design and Development